Concentrix Corporation (CNXC) Q3 FY2026 earnings

Reported results

• Revenue of $2,453.7 million, down 1.2% year-over-year on an as reported basis and down 0.5% on a constant currency basis, compared to $2,483.3 million in the prior year third quarter.
• GAAP operating loss of $910.3 million (37.1% of revenue) versus operating income of $147.0 million (5.9% of revenue) in the prior year quarter, including a non-cash goodwill impairment charge of $1,050.0 million.
• Non-GAAP operating income of $309.0 million (12.6% non-GAAP operating margin) compared to $305.1 million (12.3% non-GAAP operating margin) in the prior year quarter.
• Adjusted EBITDA of $363.0 million (14.8% adjusted EBITDA margin) compared to $359.2 million (14.5% adjusted EBITDA margin) in the prior year quarter.
• GAAP diluted loss per share of $16.24 versus GAAP diluted earnings per share of $1.34 in the prior year quarter; non-GAAP diluted earnings per share of $2.92 compared to $2.78 in the prior year quarter.
• Cash flow from operations of $268.2 million and adjusted free cash flow of $218.3 million in the quarter.

Guidance

• Q4 2026 revenue guidance: $2,410.0 million to $2,460.0 million (constant currency revenue decline of 5.0% to 3.0%); operating income of $174.0 million to $184.0 million; non-GAAP operating income of $310.0 million to $320.0 million; non-GAAP diluted EPS of $2.86 to $2.98.
• Fiscal year 2026 revenue guidance: $9,826.5 million to $9,876.5 million (constant currency revenue decline of 0.8% to 0.3%); operating loss of $522.0 million to $512.0 million; non-GAAP operating income of $1,206.0 million to $1,216.0 million; non-GAAP diluted EPS of $10.97 to $11.09.
• Fiscal year 2026 adjusted free cash flow guidance: $630.0 million to $650.0 million.

Notes

Operating loss and related metrics include a non-cash goodwill impairment charge of $1,050.0 million primarily resulting from the trading range of the Company’s stock price and market capitalization. The Board declared a quarterly dividend of $0.37 per share payable November 3, 2026. No share repurchases occurred during Q3 2026; remaining authorization was $396.6 million at August 31, 2026.

Price and volatility reaction

The stock moved +0.3% on the print. No front-expiry chain was on file, so there is no straddle expected move. 30-day ATM implied volatility moved -23.0 vol points across the event (constant-maturity series — not the front-week crush).

Source

The figures above come from the earnings release the company filed with the SEC on 2026-09-29 (8-K, Item 2.02). Read the original filing on sec.gov.